全文获取类型
收费全文 | 116682篇 |
免费 | 8783篇 |
国内免费 | 2285篇 |
专业分类
耳鼻咽喉 | 676篇 |
儿科学 | 1693篇 |
妇产科学 | 1438篇 |
基础医学 | 8970篇 |
口腔科学 | 1780篇 |
临床医学 | 17618篇 |
内科学 | 10548篇 |
皮肤病学 | 690篇 |
神经病学 | 9766篇 |
特种医学 | 2693篇 |
外国民族医学 | 3篇 |
外科学 | 9156篇 |
综合类 | 18969篇 |
现状与发展 | 10篇 |
一般理论 | 5篇 |
预防医学 | 24825篇 |
眼科学 | 935篇 |
药学 | 11478篇 |
234篇 | |
中国医学 | 3199篇 |
肿瘤学 | 3064篇 |
出版年
2024年 | 119篇 |
2023年 | 1913篇 |
2022年 | 2778篇 |
2021年 | 4665篇 |
2020年 | 5458篇 |
2019年 | 3810篇 |
2018年 | 3633篇 |
2017年 | 3734篇 |
2016年 | 4049篇 |
2015年 | 4003篇 |
2014年 | 8867篇 |
2013年 | 8980篇 |
2012年 | 8154篇 |
2011年 | 8403篇 |
2010年 | 6763篇 |
2009年 | 6084篇 |
2008年 | 6210篇 |
2007年 | 5691篇 |
2006年 | 5145篇 |
2005年 | 4191篇 |
2004年 | 3514篇 |
2003年 | 3013篇 |
2002年 | 2223篇 |
2001年 | 1903篇 |
2000年 | 1566篇 |
1999年 | 1232篇 |
1998年 | 1148篇 |
1997年 | 1030篇 |
1996年 | 865篇 |
1995年 | 850篇 |
1994年 | 818篇 |
1993年 | 714篇 |
1992年 | 638篇 |
1991年 | 648篇 |
1990年 | 505篇 |
1989年 | 436篇 |
1988年 | 447篇 |
1987年 | 420篇 |
1986年 | 379篇 |
1985年 | 527篇 |
1984年 | 436篇 |
1983年 | 276篇 |
1982年 | 287篇 |
1981年 | 265篇 |
1980年 | 253篇 |
1979年 | 155篇 |
1978年 | 145篇 |
1977年 | 124篇 |
1976年 | 95篇 |
1974年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
目的建立单抗N糖分析方法的系统适用性对照品,并设定相应的系统适用性要求。方法利用液质联用(LC-MS)仪对N糖系统适用性对照品进行N糖型的表征鉴别,并对对照品进行稳定性评价。结合方法特点和验证数据,对系统适用性要求进行设定。结果建立的系统适用性对照品具有良好的稳定性,其糖型涵盖了单抗主要的N糖型种类。针对3种药典拟收录的单抗N糖分析方法,设定了以下系统适用性要求,包括:图谱与典型图谱相似、G1F(1,6)和G1F(1,3)的分离度应满足具体要求、G0F%应在规定的范围内、G0F保留时间的RSD应≤4%。结论建立了单抗N糖系统适用性对照品,可配合3种2020年版《中国药典》拟收录的N糖分析方法使用。 相似文献
83.
Since the clinical introduction of anti-CD20 monoclonal antibodies into lymphoma treatment, immunologic approaches in lymphoma have made substantial progress. Advances in our understanding of tumor immunology have led to the development of strategies to overcome immunologic barriers responsible for an ineffective immune response. Specifically, therapeutic agents have been developed and tested against molecules that are responsible for T-cell exhaustion. The use of monoclonal antibodies against immune checkpoints in the adaptive immune system, such as programmed cell death-1 and cytotoxic T-lymphocyte-associated protein 4, has changed the landscape of cancer therapy including the treatment of lymphoma. This achievement has recently been accompanied by the development of novel immune checkpoint inhibitors targeting the innate immune system, including the CD47-SIRPα signaling pathway, and this approach has yielded promising results. To overcome impaired antigen presentation, antibody-based cytotoxic strategies, namely antibody-drug conjugates (polatuzumab vedotin and brentuximab vedotin) and bispecific T-cell or NK-cell engagers (blinatumomab, REGN1979, RG6206, and AFM13), have rapidly evolved with promising clinical activity. As additional tools become available for lymphoma treatment, formulation of safe, rational combination strategies to combine them with standard therapy will be of paramount importance. A successful approach to the treatment of lymphoma may require both an optimized anti-tumor immune response as well as effective depletion of malignant lymphoid cells. 相似文献
84.
中医药是中华民族的瑰宝,随着人工智能(Artificial Intelligence,AI)的迅猛发展,中医药与AI的结合将可以为中医药的传承和现代化提供助力。本研究将从搭建AI中医专家系统入手,阐述AI对提高中医诊断的作用,物联网搭建AI中医药服务,存在的问题和对策,以及中医药人工智能化的前景,以图为中医药的发展提供新的思路和方法。 相似文献
85.
目的通过对2019年2月-2019年6月在西安交通大学第二附属医院实习的大学四年级及大学五年级的临床医学专业的医学生就业意向及就业情况的分析,研究住院医师规范化培训制度对医学生就业的影响。方法运用自制的问卷进行匿名填写的方式对大学四年级、大学五年级的临床医学本科生及5+3模式的规范化培训医学生进行调查。结果大部分医学生选择继续升学,选择就业的学生多愿意留在大城市就业,选择住院医师规范化培训的学生只占极少数。结论做好住院医师规范化培训政策的宣传,落实各项优惠政策,鼓励学生进行住院医师规范化培训及到基层工作,引导学生理性考研,是目前社会及医学院校就业指导中的重要内容。 相似文献
86.
唐代不仅从中央到地方设立了医学专门教育机构,而且存在丰富多样的医学师徒相授和寺观宗教医学传播活动。医学教育类型多样,实施分科教学,呈现出多科性与专业性并存的特征;重视教学测评,与科举考试相结合,确立国家办学管理的地位。唐代医学教材建设取得显著成就,对医学教育人才培养发挥重要作用,它与医学教育制度一道对当代医学教育有一定的启示。 相似文献
87.
以中国近代中医药期刊为主视角,以近代中医名家为研究主体,探讨近代上海名医文化区域特征。近代上海名医多家学渊源,国学功底深厚,以文会友,在期刊阵营中思想活跃;上海为近代中医药期刊创刊的主阵地,名医办刊办学,刊学相辅,使中医教育呈现出师承、家学、院校、函授等多种模式相结合的发展趋势。生逢乱世的近代上海名医,将中医的命运与民族命运紧密相连,注重扶持民族企业,研发自主品牌,这标志着近代中医民族品牌意识开始觉醒。近代上海名医具有传统中医的特色,深受江南地域文化影响,又注重吸收和借鉴西方医学,形成了异彩纷呈的海派特色。 相似文献
88.
《结合医学学报(英文版)》2020,18(3):265-273
ObjectiveIn traditional medicine, the seeds of Thai Mucuna pruriens (T-MP) are used to treat male dysuria and are believed to enhance fertility. However, information pertaining to the toxicity of T-MP and its interaction with other properties is limited. This study was thus conducted to evaluate the antioxidant capacity and subacute toxicity of T-MP in the reproductive system.MethodsTotal phenolic content and antioxidant capacity of T-MP seed extract were determined using total phenolic content, 2,2-diphenyl-1-picrylhydrazyl and ferric reducing antioxidant power assays. Male and female adult rats were treated orally with T-MP at a dosage of 150 or 300 mg/kg body weight for 14 consecutive days. Sex hormones and functional parameters in the liver and kidney were evaluated. Histopathology of all tissue was conducted using Masson’s trichrome staining. Sperm parameters, including concentration, morphology, acrosome reaction status and DNA damage, were also examined. Expression of tyrosine phosphorylated protein (TyrPho), androgen receptor and A-kinase-anchoring protein 4 (AKAP4) were investigated using the Western blot technique.ResultsT-MP seed extract contained phenolic compounds and exhibited high antioxidant capacity with no toxicity at the tested doses. It did not affect liver or kidney function parameters in the male rats, but increased estradiol, aspartate aminotransferase and alanine aminotransferase levels in the females. Additionally, it decreased serum progesterone and alkaline phosphatase levels in female rats. Serum and intratesticular testosterone levels were significantly lower in male rats that received a high dosage of T-MP. Histopathological changes were not observed in any tissue treated with T-MP. T-MP also significantly increased sperm concentration (but did not affect sperm parameters), and enhanced testicular TyrPho protein and androgen receptor and expression of AKAP4 in sperms.ConclusionT-MP seed extract exhibited antioxidant capacity and was not harmful to reproductive tissues. It also had a phytoestrogenic effect on females and increased the expression of testicular and sperm markers of male fertility. 相似文献
89.
90.
Tiffany Li Hannah C. Timmins Tracy King Matthew C. Kiernan David Goldstein Susanna B. Park 《Hematological oncology》2020,38(3):229-243
Bortezomib-induced peripheral neuropathy (BIPN) is a common toxicity associated with the treatment of multiple myeloma (MM), typically requiring dose reduction, delay, or cessation of treatment protocol. This systematic review aimed to investigate risk factors, trends, and variability associated with the development of BIPN. Searches were undertaken using Medline, PubMed, Cochrane Central Register of Controlled Trials, Embase, Scopus, and Web of Science. Additional studies were identified by investigating authors' bibliographic references cited by original and review articles. Articles that reported on neuropathy in phase III randomised control trials involving bortezomib in any treatment arm for the treatment of MM were included in this review. A total of 43 full text articles met criteria, which examined 23 phase III trials (N = 8218). Overall incidence of neuropathy ranged from 8.4% to 80.5% (median = 37.8%) and severe neuropathy (grade 3-4) ranged from 1% to 33.2% (median = 8%). Similar reports of neuropathy of any grade and severe neuropathy were observed between the newly diagnosed and relapsed cohort. Bortezomib regimens with reduced dose intensity were associated with reduced neuropathy incidence. Increased cumulative dosing levels, intravenous compared with subcutaneous administration and combination therapy with thalidomide were associated with higher rates of BIPN. This analysis revealed that BIPN is a significant toxicity. More sensitive measures are required to capture the incidence and severity of BIPN. Better understanding of risk factors and reversibility profiles will minimise the number of cancer survivors living with residual treatment side effects. 相似文献